RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene
RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene
复制标题
DOI:
10.1136/jmg.2003.014274
复制
发表时间:
2004-03-01
影响因子:
4
通讯作者:
Robinson, R
中科院分区:
文献类型:
--
作者:
Shepherd, S;Ellis, F;Robinson, R
The congenital myopathies are a group of disorders that are difficult to distinguish. Diagnosis is frequently dependent on the result of histological examination of muscle biopsy specimens in conjunction with clinical diagnosis. There is a significant degree of overlap in the clinical features of different congenital myopathies: identification of genetic determinants may therefore aid in establishing a firm diagnosis.Central core disease (CCD) is a rare congenital myopathy. Histologically, using oxidative enzyme stains, it is identified by the abundance of central cores, characterised by localised areas of mitochondrial depletion and sarcomere disorganization exclusively in type 1 skeletal muscle fibres, and extending throughout their length. Cores are often central and unique, but may be eccentric or multiple within one fibre. Affected patients may present with congenital muscle hypotonia, pronounced proximal weakness, delayed motor development, and slightly elevated creatine kinase (CK) levels. In addition, skeletal anomalies such as congenital hip displacement and scoliosis are frequent. Later in life muscle strength may improve, but in rare cases progressive muscle weakness is observed. Respiratory insufficiency is rare. 1 2 Overall, the disorder demonstrates significant phenotypic variability; in a study of 13 cases, as many as 40% of patients with histological signs of disease were clinically asymptomatic. 3